Immunization with a Genetically Engineered Uropathogenic Escherichia coli Adhesin-Escherichia coli Enterotoxin Subunit A2B Chimeric Protein

  • Lee, Yong-Hwa (Division of Immunopharmacology, College of Pharmacy SungKyunKwan University) ;
  • Kim, Byung-O (College of Life Science and Natural Resources, Sanju National University) ;
  • Pyo, Suhk-Neung (Division of Immunopharmacology, College of Pharmacy SungKyunKwan University)
  • Published : 2005.06.01

Abstract

The generation of secretory IgA antibodies (Abs) for specific immune protection of mucosal surfaces depends on stimulation of the mucosal immune system, but this is not effectively achieved by parenteral or even oral administration of most soluble antigens. Thus, to produce a possible vaccine antigen against urinary tract infections, the uropathogenic E. coli (UPEC) adhesin was genetically coupled to the heat-labile Escherichia coli enterotoxin A2B (ltxa2b) gene and cloned into a pMAL-p2E expression vector. The chimeric construction of pMALfimH/ltxa2b was then transformed into E. coli K-12 TB1 and its nucleotide sequence was verified. The chimeric protein was then purified by applying the affinity chromatography. The purified chimeric protein was confirmed by SDS-PAGE and westem blotting using antibodies to the maltose binding protein (MBP) or the heat labile E. coli subunit B (LTXB), plus the N-terminal amino acid sequence was analyzedd. The orderly-assembled chimeric protein was confirmed by a modified $G_{M1}$-ganglioside ELISA using antibodies to adhesin. The results indicate that the purified chimeric protein was an Adhesin/LTXA2B protein containing UPEC adhesin and the $G_{M1}$-ganglioside binding activity of LTXB. thisstudy also demonstrate that peroral administration of this chimeric immunogen in mice elicited high level of secretory IgA (sIgA) and serum IgG Abs to the UPEC adhesin. The results suggest that the genetically linked LTXA2B acts as a useful mucosal adjuvant, and that adhesin/LTXA2A chimeric protein might be a potential antigen for oral immunization against UPEC.

Keywords

References

  1. Abraham, S. N., Sun, D., Dale, J. B., and Beachey, E. H. (1988). Conservation of the D-mannose-adhesion protein among type 1 fimbriated members of the family. Enterobacteriaceae. Nature 336, 682-684 https://doi.org/10.1038/336682a0
  2. Beachey, E. H., Giampapa, C. S., and Abraha, S. N. (1988). Bacterial adherence: adhesin receptor-mediated attachement of pathogenic bacteria to mucosal surfaces. Am. Rev. Resp. Dis. 138, S45-S48 https://doi.org/10.1164/ajrccm/138.6_Pt_2.S45
  3. Dallas, W. S., and Falkow, S. (1980). Amino acid sequence homology between cholera toxin and Escheichia coli heat-labile toxin. Nature 288, 499-501 https://doi.org/10.1038/288499a0
  4. Douce, G., Giannelli, V., Pizza, M., Lewis, D., Everest, P., Rappuoli, R., and Dougan, G. (1999). Genetically detoxified mutants of heat-labile toxin from Escherchia coli are able to act as oral adjuvants. Infect. Immun. 67(9), 4400-4406
  5. Elson, C. O., Ealding, W., and Lefkowitz. J. (1984). A Lavage Technique Allowing Repeated Measurement of IgA Antibody in Mouse Intestinal Secretions. J Immunol. Methods 67, 101-108 https://doi.org/10.1016/0022-1759(84)90089-9
  6. Haan, L. D., Holtrop, M., Verweij, W. R., Agsteribbe, E. and Wilschut, J. (1996). Mucosal immunogenicity of the Escherichia coli heat-labile enterotoxin: role of the A subunit. Vaccine 14(4), 260-266 https://doi.org/10.1016/0264-410X(95)00235-S
  7. Hajishengallis, G., Hollingshead, S. K., Koga, T. and Russell, M. W. (1995). Mucosal Immunization with a Bacterial Protein Antigen Genetically Coupled to Cholera Toxin A2/B Subunits. J Immunol. 154, 4322-4332
  8. Kim, B. O., Shin, S. S., Yoo, Y. H. and Pyo, S. (2001). Peroral immunication with Helicobacter pylori adhesin protein genetically linked to cholera toxin A/2B subunits. Clin. Sci. 100, 292-298
  9. Knudsen, T. B. and Klemm, P. (1998). Probing the receptor recognition site of the FimH adhesin by fimbirae-displayed fimH-FocH hybrids. Microbial. 144, 1919-1929 https://doi.org/10.1099/00221287-144-7-1919
  10. Langermann, S., Palaszynski, S., Barnhart, M., Auguste, G., Pinkner, J. S., Burlein, J., Barren, P., Koenig, S. K., Leath, S., Jones, C. H. and Hultgren, S. J. (1997). Prevention of Mucosal Escherichia coli Infection by FimH-Adhesin-Based Systemic Vaccination. Science 276(25), 607-611 https://doi.org/10.1126/science.276.5312.607
  11. Nashar, T. O., Amin, T., Marcello, A. and Hirst, T. R. (1993). Current progress in the development of the B subunits of cholera toxin and Escherichia coli heat-labile enterotoxin as carriers for the oral delivery of heterologous antigens and epitopes. Vaccine 11(2), 235-240 https://doi.org/10.1016/0264-410X(93)90023-Q
  12. Neu, H. C. and Heppel, L. A. (1965). The Release of Enzyme from Escherichia coli by Osmotic Shock and during the Formation of Spheroplasts. J Biol. Chem. 240(9), 3685-3692
  13. Pizza, M., Giuliani, M. M., Fontana, M. R., Monaci, E., Douce, G., Dougan, G., Mills, K. H. G., Rappuoli, R., Giudice, G. D. (2001). Mucosal vaccine: non toxic derivatives of LT and CT as mucosal adjuvants. Vaccine 19, 2534-2541 https://doi.org/10.1016/S0264-410X(00)00553-3
  14. Rappuoli, R., Pizza, M., Douce, G, Dougan, G. (1999). Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins. Immunol. Today 20(11), 493-500 https://doi.org/10.1016/S0167-5699(99)01523-6
  15. Rodighiero, C., Aman, A. T., Kenny, M. J., Moss, J., Lencer, W. L, and Hirst, T. R. (1999). Structure basis for the differential toxicity of cholera toxin and Escherichia coli heat-labile enterotoxin. J Biol Chem. 274, 3962-3969 https://doi.org/10.1074/jbc.274.7.3962
  16. Sauer, F. G., Mulvey, M. A., Schilling, J. D., Marinez, J. J. and Hultgren, S. J. (2000). Bacterial pili: molecular mechanism of pathogenesis. Curr. Opin. Microbial. 3, 65-72 https://doi.org/10.1016/S1369-5274(99)00053-3
  17. Uehiling, D. T., Hopkins, W. J., Dahmer, L. A. and Balish, E. (1994). Vaginal mucosal immunization in recurrent UTls. J Ural. 152(6 Pt 2), 2308-2311 https://doi.org/10.1016/S0022-5347(17)31664-6